Castle Biosciences signals $385M-$395M 2026 revenue outlook as TissueCypher targets 50%-52% volume growth

Nigeria South Africa Senegal Ghana Uganda Kenya Morocco Egypt Zimbabwe Tanzania Algeria Ethiopia Ivory Coast Sudan Libya Somalia Zambia Tunisia Mozambique DR Congo Angola

India Malaysia South Korea China Israel Iran Philippines United Arab Emirates Japan Saudi Arabia Turkey Cambodia Singapore Pakistan Indonesia Thailand North Korea Vietnam Yemen Palestine Nepal Taiwan Kazakhstan Bangladesh Iraq Lebanon Syria Qatar Sri Lanka Afghanistan Jordan Uzbekistan Kuwait Laos

United Kingdom Germany Russia Spain France Italy Ukraine Portugal Ireland Austria Finland Switzerland Romania Netherlands Greece Poland Czech Republic Hungary Sweden Norway Denmark Belgium Serbia Croatia Bulgaria Georgia Slovakia Belarus Slovenia Iceland

United States Mexico Canada Dominican Republic Costa Rica Guatemala Puerto Rico Honduras Jamaica Cuba Panama Belize Nicaragua El Salvador Haiti Bahamas Trinidad and Tobago Barbados

Brazil Peru Colombia Argentina Ecuador Venezuela Bolivia Uruguay Chile Paraguay

Australia New Zealand Papua New Guinea Fiji